Results: DER and SER increase as the distance of the GNPs reduces. The largest DER as well as SER was obtained for 0.25 × 0.25 × 0.25 μm³ cube for 100 nm 0.18 × 0.18 × 0.18 μm³ for 50 nm GNP. In case of 50 nm GNPs, DER increment was 1.421, 1.396, 1.017, and 1.014 for 50 kVp, 100 kVp photons, 70 MeV and 170 MeV protons, respectively. SER increment was 1.319, 1.303, 1.021, and 1.018, for 50 kVp, 100 kVp photons, 70 MeV and 170 MeV protons, respectively. For 100 nm GNPs, we observed the qualitatively same results but increment ratio was larger for all tested radiations.
Material and Methods:
Firstly, to verify the imaging detectability of Fe3O4/TaOx nano particles, in-vivo tests were conducted. Approximately 600 mg/kg of19 nm diameter Fe3O4/TaOx nano particles dispersed in phosphate buffered saline (PBS) were injected to ten nude Balb/c mice through the tail vein. Mico-CT (Simens Inveon) was scanned for 5 mice and MRI (BioSpec, 70/20 USR, BRUKER Co.) scan was conducted for rest of mice. For both imaging, 4 consecutive scanning was performed at pre-and post-injection (5 min, 30 min, and 1 hour). Difference between pre-and post-injection images was analyzed by computing the pixel histogram and correlation coefficient factor using MATLAB in the user defined ROI (region of interests) . Secondly, to quantify the potential therapeutic enhancement with nano materials, DER (Dose Enhancement Ratio) and number of SER (Secondary Electron Ratio) were computed using MC simulation . Diameter of 19 nm circular beams of mono-energetic 10 MeV, 70 MeV, 150 MeV protons were irradiated to a Gold(Au), Tantalum(Ta), TaOx, Fe3O4/TaOx (core / shell), and Fe3O4 nano particle located at the center of 4 × 4 × 4 μm³ water filled cube phantom. DER and SER were computed by placing a 1 nm thickness of shell detector at the surface of the particle.
Results:
In CT, MRI imaging, the aorta, the blood vessel, and the liver were clearly visualized after intravenous injection of Fe3O4/TaOx nano particles. There was large different between pre and post-injection images of Histogram data and Coefficients of correlation factor in CT and MR are 0.006, 0.060, respectively. When 10 MeV protons were irradiated for a Gold(Au), Tantalum(Ta), TaOx, Fe3O4/TaOx, Fe3O4 nano particle, DER was 9. 089, 7.724, 4.424, 3.660 and 3.255 respectively. Similarly, SER increment was 9. 629, 8.401, 5.060, 4.341, and 3.590 for Gold(Au), Tantalum(Ta), TaOx, Fe3O4/TaOx, Fe3O4 nano particle, respectively. For 70 MeV proton beams, DER was similar to those for 10 MeV, but increment ratio was lower for 150 MeV protons.
Conclusion: Fe3O4/TaOx nano particles have potential as a multifunctional agent which enhances the accuracy in cancer detection through visualization of developed tumor lesion and increases the therapeutic effect in proton therapy. 
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Purpose or Objective: The goal of radiotherapy is to deliver into tumor volume certain amount of radiation to kill all tumor cells and at the same time to minimize radiation damage of surrounding healthy tissues. To reach the goal modern conventional radiotherapy uses multifield irradiation with beam changing its shape and intensity. However this approach is not efficient enough in case when healthy and tumor tissues are highly diffused with each other. In this case partial healthy tissues damage is inevitable. Yet another approach is possible. Using some physiological mechanism tumor can be saturated with a high atomic number element capable to interact with external radiation more likely than the elements of biological tissues. That leads to dose increase at the site of the element location. For that purpose such elements as iodine, gold etc. and external x-rays radiation of energy up to 600 keV can be used. The main obstacle in implementing that method is how to deliver necessary amount of a high atomic number element into a tumor. Attempts of developing tumor targeting drug, which would be capable to deliver necessary amount of high atomic number element into the tumor haven't succeed yet. Another possible way to deliver such elements into the tumor is to utilize some pathological processes caused by tumorogenesis such as blood barrier disruption in case of brain tumors or high vascularization inherent to some tumors. In this work the efficacy of x-rays irradiation with disodium gadopentetate (Gd-DTPA) administration in treating highly vascularized transplanted tumor in mice was studied.
Material and Methods: C57Bl/6 mice with transplanted adencarcinoma Ca755 were used in the study. Animals were divided into three groups. 1st group undergo no treatment. 2nd group was irradiated with 10 Gy of x-rays. Animals in 3rd group were administered with 0.3 ml of 0.5M water solution of Gd-DTPA, containing 23 mg of gadolinium and then irradiated as well. Administration of Gd-DTPA was performed with single systemic injection. Irradiation was performed using x-rays generator with anode voltage of 200 kV. Antineoplastic efficacy was estimated by measuring tumor volume and life span of mice.
Results: Tumor growth rate plots are presented in Figure. Tumor growth delay for test group was 13 days whereas in irradiated control group tumor growth delay was just 4 days. Median life span was 22 days, 37 days and 46 days for control group, irradiated control group and test group respectively. In test group 25% of animals have full tumor regression whereas in both control groups no tumor regression was observed. Endpoints of antitumor evaluation, i.e. T/C% ratio and gross log10 tumor cell kill are represented in Table. Conclusion: Obtained results show that systemic injection of extracellular drug with gadolinium prior irradiation with xrays provide enough amount of gadolinium in highly vascularized tumors and lead to significant increase of antineoplastic efficacy of x-rays irradiation. Purpose or Objective: With the development of molecular biology and gene engineering，more and more attention has been paid to gene-radiotherapy of malignant tumors. The combination of gene therapy and radiotherapy is regarded as one of the effective methods for the treatment of tumors. This research focused on the Egr-1 promoter with radiationinduced effect, p53 and endostatin genes with function of inducing apoptosis and anti-angiogenesis, and EGFR-targeted adenovirus vector with higher cell infection efficiency. The therapeutic effect of adenovirus vectors Ad.Egr-wtp53endostatin and Ad.CMV-sCAR-EGF combined with radiotherapy in non-small cell lung cancer is here reported.
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Material and Methods:
The adenovirus vectors Ad.Egr-wtp53endostatin containing both wild type p53 and antiangiogenic molecule endostatin genes downstream of early growth response-1 (Egr-1) and Ad.CMV-sCAR-EGF containing coxsackie virus receptor extracellular segment (sCAR) and epidermal growth factor (EGF) were constructed using gene recombination technique. The infection efficiency in nonsmall cell lung cancer cell lines (A549, LK-2 and Lu65) of Ad.Egr-wtp53-endostatin mediated with Ad.CMV-sCAR-EGF expressed fusion protein sCAR-EGF was detected. The expression of wild type p53 and endostatin genes by the radiation-sensitive promoter Egr-1 in non-small cell lung cancer cell lines were observed. Immunodeficient mice (NOD/scid) subcutaneously implanted with A549 cells were treated by conventional radiotherapy (2Gy×6) and/or gene therapy (intratumor injection of adenovirus vectors Ad.Egr-wtp53-endostatin and Ad.CMV-sCAR-EGF 24 h before the first and fourth local doses). Immunologic mechanisms were explored.
Results:
The fusion protein SCAR-EGF expressed from Ad.CMV-sCAR-EGF significantly increased infection efficiency of Ad.Egr-wtp53-endostatin in human non-small cell lung cancer cell lines. Cancer control was most significantly improved in the group receiving local radiotherapy combined with gene therapy as shown by prolongation of mean survival time by 75.2%, reduction in average tumor weight by 88.7%, decrease in pulmonary metastasis by 76.9% and decrease in intratumor angiogenesis by 80.4% as compared to local radiotherapy alone (P < 0.05). Immunologic studies showed stimulated natural killer (NK) and cytotoxic T lymphocyte (CTL) activity as well as increased interferon-γ (IFN-γ) and tumor necrosis factor-α (TNF-α) secretion in this combined treatment group as compared with the group receiving local treatment alone (P < 0.05).
Conclusion:
The experimental findings in the present study showed that adenovirus vectors Ad.Egr-wtp53-endostatin and Ad.CMV-sCAR-EGF in combination with local radiotherapy could improve the tumor control. These observations may set the stage for developing clinical protocols with recombinant adenovirus-mediated gene-radiotherapy in non-small cell lung cancer. Purpose or Objective: One of the main effects of radiotherapy is the generation of free radicals as a consequence of the incidence of radiation on the aqueous molecules present in the cells. The enzyme D-aminoacid oxidase (DAO) is also able to generate free radicals when converting D-aminoacids in their corresponding cetoacids. Our principal aim is to increase radiotherapy effects, using
EP-2032
